BAM vs ING

The Advanced Deterministic Scorecard reveals a weak Piotroski F-Score of 3/9, indicating poor financial health, which raises concerns despite strong profitability and growth metrics. The absence of an Altman Z-Score prevents a full distress risk assessment, but the low Piotroski score suggests operational or balance sheet weaknesses. While the company exhibits robust ROE (22.57%), high margins, and strong earnings growth (34.3% YoY), these are offset by an elevated valuation (P/E 33.29, P/B 9.77) and a concerning 109.19% payout ratio that threatens dividend sustainability. Price performance has weakened recently, with a 1Y return of -9.3%, and insider sentiment is neutral, offering no catalysts.

ING presents a stark contrast between deep value and deteriorating fundamental health. While the stock trades significantly below its Graham Number ($34.91) and Intrinsic Value ($73.16), the Piotroski F-Score of 2/9 indicates weak financial health and operational deterioration. Despite anomalous YoY growth figures and a strong dividend profile, the bearish technical trend (0/100) and low insider sentiment suggest caution. The valuation is attractive, but the fundamental health score acts as a significant drag on a bullish rating.